Skip to content
Home/Companies/Biotech/Meiogenix
Meiogenix

Meiogenix

Biotech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Meiogenix?

Meiogenix is currently owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage), since 2019.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQFrance
SectorBiotech
Websitemeiogenix.com

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Arzeda
Active
BiotechUS· 2022
IB Works I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Novameat
Active
BiotechSpain· 2021
Qorium
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Meiogenix

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Meiogenix?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Meiogenix.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue